Posted by Noah T. Ditto
The Carterra LSA is making screening for large numbers of biotherapeutic targets a more effective and revealing process by using high-throughput Surface Plasmon Resonance (HT-SPR). We will share how the LSA can measure 1,152 kinetic interactions or as many as 150,000 binning reactions within a single experiment while requiring as little as 2 µL of either crude or purified sample. Driving these processes is cutting edge software delivering novel features and ways of maximizing data impact from every experiment. Learn how leading scientists are shifting the paradigm by confidently characterizing, selecting, and bringing novel drugs to market using the LSA and its highly dedicated software packages.
What you will learn:
- The latest improvements to the LSA platform’s software that are enabling researchers to develop a deeper characterization of their biotherapeutic candidates
- Ways leading scientists are overcoming their biotherapeutic screening and discovery challenges with the LSA
- How the Carterra LSA can change the way you approach biotherapeutic development and characterization
Noah T. Ditto, Technical Product Manager, Carterra
Noah T. Ditto drives the development of transformative High Throughput Surface Plasmon Resonance (HT-SPR) hardware and software solutions as Technical Product Manager at Carterra. Prior to joining Carterra in 2014, Noah supported Drug Discovery and Early Clinical Development for nearly a decade at Bristol-Myers in Princeton, NJ with a focus on biophysical characterization of protein and peptide-based biomarkers, drug targets, and therapeutics. Noah earned an MS from Pennsylvania State University developing chromatography-based fractionation techniques to isolate disease-specific serum biomarkers in Dengue infection and more recently an MBA from West Chester University focusing on business analytics.
Peter has over 25 years of industry experience developing, commercializing and marketing products in the life science sector. Peter is currently the Senior Product Marketing Manager at Carterra and responsible for the LSA and new product launches. Peter previously worked for NanoTemper Technologies, Biocompare, ProteinSimple and Molecular Devices. He did his post-doctoral studies at the Worcester Foundation, received his Ph.D. in molecular and cellular biology from Syracuse University, and a B.S. in molecular biology from Iowa State University.